ICAM1 and bladder transitional cell carcinoma: These findings not only reinforce the role of TSP4 as a pro-metastatic factor but also identify ICAM-1 and integrin αvβ3 as potential therapeutic targets to disrupt TSP4-mediated lymphatic dissemination in BLCA.